Useful bacteria

BioGaia

BioGaia develops, markets and sells probiotic products. Probiotics are useful bacteria that have documented positive health effects in the body. The applications for BioGaia products are mainly in gastrointestinal, oral and immune health and the products are available in a variety of different types of bottles. Sales are mainly through distribution partners in pharmacies worldwide. The company has two business areas: Pediatrics and Adult Health.

Financials

BIOGAIA

SEKm 2017 2018 2019
Sales 615 706 801
Sales growth (%) 15 14,8 13,4
EBITDA 240 267 285
EBITDA margin (%) 39,1 37,9 35,5
EBIT adj 234 261 277
EBIT adj margin (%) 38 36,9 34,6
Pretax profit 233 261 277
EPS rep 10,48 11,75 12,47
EPS growth (%) -16,1 12,1 6,1
EPS adj 10,48 11,75 12,47
DPS 9 9 9,5
EV/EBITDA (x) 22,2 21,6 20,2
EV/EBIT adj (x) 22,8 22,2 20,8
P/E (x) 31,1 30 28,3
P/E adj (x) 31,1 30 28,3
EV/sales (x) 8,7 8,2 7,2
FCF yield (%) 3,5 2,7 3,1
Dividend yield (%) 2,8 2,6 2,7
Net IB debt/EBITDA -1,3 -1,2 -1,2

Main shareholders

BioGaia

Main shareholders Share capital % Voting shares % Verified
Peter Rotschild & Jan Annwall 7.2 % 33.0 % 30 Sep 2018
Swedbank Robur Fonder 9.4 % 6.8 % 30 Sep 2018
Fjärde AP-fonden 7.6 % 5.5 % 30 Sep 2018
Sebastian Jahreskog 6.9 % 5.0 % 28 Oct 2016
David Dangoor 3.0 % 2.2 % 31 Dec 2017
Juno Investment Partners 2.4 % 1.7 % 30 Jun 2018
Didrik Hamilton 1.4 % 1.0 % 30 Sep 2018
Tredje AP-fonden 1.4 % 1.0 % 30 Sep 2018
Dimensional Fund Advisors 1.3 % 0.9 % 31 Aug 2018
Allianz Global Investors 1.3 % 0.9 % 31 Jul 2018

Insider list

BioGaia

Name
Isabelle Ducellier
Annwall & Rothschild Investments AB
Åsa Skansjö Sjöblad
Welin-Berger, Katayoun
Welin-Berger, Katayoun
Welin-Berger, Katayoun
Magnusson Borg, Kristina
Hagman, Margareta
Hagman, Margareta
Hagman, Margareta
Show More